
Opinion|Videos|January 31, 2025
Patient Selection for Aflibercept 8 mg
Panelists discuss how ideal candidates for aflibercept 8 mg include patients with stable disease on current anti-VEGF therapy who seek reduced treatment burden, newly diagnosed patients, and those demonstrating good response to initial loading doses.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Who is the ideal patient for aflibercept 8 mg?
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
















































